<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-89623</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">201Thalium SPECT in the detection of recurrent laryngeal carcinoma</dc:title>
<dc:description xml:lang="en">Objective. To evaluate the diagnostic yield of 201Thallium SPECT in the detection of local and/or regional lymph node dissemination of pharyngolaryngeal carcinoma. Material and methods. 29 patients who had been diagnosed with pharyngolaryngeal carcinoma were studied (mean age: 60.9 years). These patients had been treated by surgery, chemotherapy and radiotherapy. At between 3 to 6 month after finishing the treatment, all of them underwent a planar and SPECT study at one hour after the administration of 148 MBq of 201Thallium. Uptake was scored on four grades: from 0 (no uptake) to 3 (very intense uptake). The presence or non-presence of lymph nodes with uptake was also evaluated. All the results on the scintigraphy were correlated with long term clinical and radiological follow-up (mean: 2.5 years). The studies were classified as positive for recurrence when the uptake was 2-3 and/or with presence of lymph nodes with uptake. Results. We obtained 9 true positive, 14 true negative, 3 false positive and 3 false negative results. Sensitivity was 75%, specificity was 82.4%, positive predictive value was 75% and negative predictive value was 82.4%. Two out of three false positives corresponded to the surgical bed uptake and one was attributed to the laterocervical lymph nodes. The three false negatives had grade 1 uptakes, two of them corresponding to pulmonary metastasis without evidence of local recurrence. Conclusions. The use of 201Thallium SPECT in the prognostic evaluation in patients with a treated laryngeal carcinoma shows very acceptable results in the detection of local recurrence and/or regional lymph node dissemination(AU)</dc:description>
<dc:creator>Castell Conesa, J</dc:creator>
<dc:creator>Rubió Rodríguez, A</dc:creator>
<dc:creator>Lorente Guerrero, J</dc:creator>
<dc:creator>González Doñate, M</dc:creator>
<dc:creator>García López, M</dc:creator>
<dc:creator>Boronat de Ferrater, M</dc:creator>
<dc:creator>Negre Busó, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Evaluar el rendimiento del SPECT con 201Talio en la detección de la recidiva local y/o diseminación ganglionar regional del carcinoma faringolaríngeo. Material y métodos. Se estudiaron 29 pacientes con el diagnóstico de carcinoma faringolaríngeo (media: 60,9 años), tratados con cirugía, quimioterapia y radioterapia. Entre 3 a 6 meses después de finalizar el tratamiento, a todos se les practicó un estudio planar y SPECT una hora después de la administración de 148 MBq de 201Talio. La captación se valoró en 4 grados (0 no captante-3 muy intenso) y se constató la presencia o no de ganglios captantes. El resultado gammagráfico se correlacionó con el seguimiento clínico y radiológico a largo plazo (media: 2,50 años). Se valoraron como positivos de recurrencia, los estudios con captación centrocervical focal de grado 2-3 o la presencia de adenopatías captantes. Resultados. Se obtuvieron 9 verdaderos positivos, 14 verdaderos negativos, tres falsos positivos y tres falsos negativos. La sensibilidad fue del 75%, la especificidad del 82,4%, el valor predictivo positivo del 75% y el valor predictivo negativo del 82,4%. De los tres falsos positivos, dos correspondieron a captaciones en el lecho quirúrgico y uno a captación atribuida a ganglios laterocervicales. Los tres falsos negativos presentaron captaciones de grado 1, correspondiendo dos de ellos a metástasis pulmonares sin evidencia de recidiva local. Conclusión. El uso del SPECT con 201Talio en la evaluación pronóstica del paciente con carcinoma de laringe tratado muestra unos resultados muy aceptables para la detección de recidiva local y/o diseminación ganglionar regional(AU)</dc:description>
<dc:source>Rev Esp Med Nucl;30(4): 236-240, jul.-ago. 2011.</dc:source>
<dc:identifier>ibc-89623</dc:identifier>
<dc:title xml:lang="es">El SPECT con 201Talio en la detección de recidiva del carcinoma de laringe</dc:title>
<dc:subject>^d24895^s22045</dc:subject>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28150^s22016</dc:subject>
<dc:subject>^d23037</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d28150^s22057</dc:subject>
<dc:subject>^d28150^s22059</dc:subject>
<dc:subject>^d28150^s29166</dc:subject>
<dc:subject>^d28606</dc:subject>
<dc:subject>^d24895^s22074</dc:subject>
<dc:subject>^d13195</dc:subject>
<dc:subject>^d9557^s29166</dc:subject>
<dc:type>article</dc:type>
<dc:date>201108</dc:date>
</metadata>
</record>
</ibecs-document>
